Javascript must be enabled to continue!
Neutrophil Cathepsin G Enhances Thrombogenicity of Mildly Injured Arteries via ADP-Mediated Platelet Sensitization
View through CrossRef
Inhalation of particulate matter in polluted air causes direct, size-restricted passage in the circulation and pronounced lung inflammation, provoking platelet activation and (non)-fatal cardiovascular complications. To determine potency and mechanism of platelet sensitization via neutrophil enzymes, we performed in vitro aggregation studies in washed human platelets and in murine and human blood, in the presence of elastase, cathepsin G and regular platelet agonists, present in damaged arteries. The impact of both enzymes on in vivo thrombogenicity was studied in the same thrombosis mouse model, previously having demonstrated that neutrophil activation enhances peripheral thrombogenicity. At 0.05 U/mL, cathepsin G activated washed human platelets via PAR1, whereas at 0.35 U/mL, aggregation occurred via PAR4. In Swiss mouse platelet-rich plasma no aggregation occurred by cathepsin G at 0.4 U/mL. In human and murine blood, aggregations by 0.05–0.1 U/mL cathepsin G were similar and not PAR-mediated, but platelet aggregation was inhibited by ADP antagonists, advocating cathepsin G-released ADP in blood as the true agonist of sustained platelet activation. In the mouse thrombosis model, cathepsin G and elastase amplified mild thrombogenicity at blood concentrations that activated platelets in vitro. This study shows that cathepsin G and elastase secreted in the circulation during mild air pollution-induced lung inflammation lyse red blood cell membrane proteins, leading to ADP-leakage into plasma, sensitizing platelets and amplifying their contribution to cardiovascular complications of ambient particle inhalation.
Title: Neutrophil Cathepsin G Enhances Thrombogenicity of Mildly Injured Arteries via ADP-Mediated Platelet Sensitization
Description:
Inhalation of particulate matter in polluted air causes direct, size-restricted passage in the circulation and pronounced lung inflammation, provoking platelet activation and (non)-fatal cardiovascular complications.
To determine potency and mechanism of platelet sensitization via neutrophil enzymes, we performed in vitro aggregation studies in washed human platelets and in murine and human blood, in the presence of elastase, cathepsin G and regular platelet agonists, present in damaged arteries.
The impact of both enzymes on in vivo thrombogenicity was studied in the same thrombosis mouse model, previously having demonstrated that neutrophil activation enhances peripheral thrombogenicity.
At 0.
05 U/mL, cathepsin G activated washed human platelets via PAR1, whereas at 0.
35 U/mL, aggregation occurred via PAR4.
In Swiss mouse platelet-rich plasma no aggregation occurred by cathepsin G at 0.
4 U/mL.
In human and murine blood, aggregations by 0.
05–0.
1 U/mL cathepsin G were similar and not PAR-mediated, but platelet aggregation was inhibited by ADP antagonists, advocating cathepsin G-released ADP in blood as the true agonist of sustained platelet activation.
In the mouse thrombosis model, cathepsin G and elastase amplified mild thrombogenicity at blood concentrations that activated platelets in vitro.
This study shows that cathepsin G and elastase secreted in the circulation during mild air pollution-induced lung inflammation lyse red blood cell membrane proteins, leading to ADP-leakage into plasma, sensitizing platelets and amplifying their contribution to cardiovascular complications of ambient particle inhalation.
Related Results
PATHOPHYSIOLOGY OF THROMBOCYTOPENIA AND RESULTANT CLINICAL INDICATIONS FOR PLATELET TRANSFUSION
PATHOPHYSIOLOGY OF THROMBOCYTOPENIA AND RESULTANT CLINICAL INDICATIONS FOR PLATELET TRANSFUSION
Careful evaluation of platelet survival data in normal individuals and patients with thrombocytopeniasecondary to marrow aplasia has demonstrated that platelets are lost from circu...
Abstract 1505: The role of cathepsin B in colorectal tumorigenesis
Abstract 1505: The role of cathepsin B in colorectal tumorigenesis
Abstract
Many cancers express elevated protease levels which contribute to certain aspects of tumor behavior such as growth and metastatic spread. Specifically, elev...
GRK2 Regulates ADP Signaling in Platelets Via P2Y 1 and P2Y 12
GRK2 Regulates ADP Signaling in Platelets Via P2Y 1 and P2Y 12
Abstract
Abstract
Venous thromboembolism (VTE), heart attack, and stroke are all diseases in which platelets play a role, through inappropriate platel...
Cathepsin H (EC 3.4.22.16)
Cathepsin H (EC 3.4.22.16)
Abstract
In 1976 Kirschke and co-workers [169] named a lysosomal peptidase cathepsin H. This enzyme was termed L20C21 in 1972 by the same authors [340] and later ...
ADP-INDUCED CYTOPLASMIC CALCIUM MOBILIZATION AND SHAPE CHANGE IN PLATELETS ARE MEDIATED BY DIFFERENT BINDING SITES
ADP-INDUCED CYTOPLASMIC CALCIUM MOBILIZATION AND SHAPE CHANGE IN PLATELETS ARE MEDIATED BY DIFFERENT BINDING SITES
Platelet stimulation with ADP results in a number of responses including increase in cytoplasmic ionized calcium concentration [Ca2+]i, shape change, aggregation, secretion, and in...
e0517 Forearm arteries with ultrasound for percutaneous coronary procedures
e0517 Forearm arteries with ultrasound for percutaneous coronary procedures
Background
The radial artery has become a widely used approach for coronary angiography and intervention in patients, and the ulnar artery is another approach for...
ADP Binding Proteins in Thrombasthenic Platelet Membranes
ADP Binding Proteins in Thrombasthenic Platelet Membranes
Thrombasthenia is a severe congenital platelet disorder characterized by absence of ADP-induced platelet aggregation, diminished clot retraction and abnormalities of platelet membr...
Cathepsin B (EC 3.4.22.1)
Cathepsin B (EC 3.4.22.1)
Abstract
In 1941 Fruton and co-workers [1377] proposed a classification of the proteolytic enzymes of animal tissues in which they included an enzyme that hydroly...

